Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Feed Yeast Market

ID: MRFR/Agri/3758-HCR
90 Pages
Snehal Singh
Last Updated: April 28, 2026

Feed Yeast Market Size, Share, Industry Trend & Analysis Global Research Report Information by Type (Live Yeast, Spent Yeast, Yeast Derivatives and others), Form (Powder, Liquids and others), Livestock (Ruminants, Poultry, Swine and others) and Region (North America, Europe, Asia-Pacific and Rest of the World) - Forecast till 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Feed Yeast Market Infographic
Purchase Options
  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
    1. 1.1 EXECUTIVE SUMMARY | |
      1. 1.1.1 Market Overview | |
      2. 1.1.2 Key Findings | |
      3. 1.1.3 Market Segmentation | |
      4. 1.1.4 Competitive Landscape | |
      5. 1.1.5 Challenges and Opportunities | |
      6. 1.1.6 Future Outlook 2
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
    1. 2.1 MARKET INTRODUCTION | |
      1. 2.1.1 Definition | |
      2. 2.1.2 Scope of the study | | |
        1. 2.1.2.1 Research Objective | | |
        2. 2.1.2.2 Assumption | | |
        3. 2.1.2.3 Limitations |
    2. 2.2 RESEARCH METHODOLOGY | |
      1. 2.2.1 Overview | |
      2. 2.2.2 Data Mining | |
      3. 2.2.3 Secondary Research | |
      4. 2.2.4 Primary Research | | |
        1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
        2. 2.2.4.2 Breakdown of Primary Respondents | |
      5. 2.2.5 Forecasting Model | |
      6. 2.2.6 Market Size Estimation | | |
        1. 2.2.6.1 Bottom-Up Approach | | |
        2. 2.2.6.2 Top-Down Approach | |
      7. 2.2.7 Data Triangulation | |
      8. 2.2.8 Validation 3
  3. SECTION III: QUALITATIVE ANALYSIS |
    1. 3.1 MARKET DYNAMICS | |
      1. 3.1.1 Overview | |
      2. 3.1.2 Drivers | |
      3. 3.1.3 Restraints | |
      4. 3.1.4 Opportunities |
    2. 3.2 MARKET FACTOR ANALYSIS | |
      1. 3.2.1 Value chain Analysis | |
      2. 3.2.2 Porter's Five Forces Analysis | | |
        1. 3.2.2.1 Bargaining Power of Suppliers | | |
        2. 3.2.2.2 Bargaining Power of Buyers | | |
        3. 3.2.2.3 Threat of New Entrants | | |
        4. 3.2.2.4 Threat of Substitutes | | |
        5. 3.2.2.5 Intensity of Rivalry | |
      3. 3.2.3 COVID-19 Impact Analysis | | |
        1. 3.2.3.1 Market Impact Analysis | | |
        2. 3.2.3.2 Regional Impact | | |
        3. 3.2.3.3 Opportunity and Threat Analysis 4
  4. SECTION IV: QUANTITATIVE ANALYSIS |
    1. 4.1 Healthcare, BY Type (USD Billion) | |
      1. 4.1.1 Live Yeast | |
      2. 4.1.2 Spent Yeast | |
      3. 4.1.3 Yeast Derivatives | |
      4. 4.1.4 Others |
    2. 4.2 Healthcare, BY Form (USD Billion) | |
      1. 4.2.1 Powder | |
      2. 4.2.2 Liquid | |
      3. 4.2.3 Others |
    3. 4.3 Healthcare, BY Livestock (USD Billion) | |
      1. 4.3.1 Ruminants | |
      2. 4.3.2 Poultry | |
      3. 4.3.3 Swine | |
      4. 4.3.4 Others |
    4. 4.4 Healthcare, BY Region (USD Billion) | |
      1. 4.4.1 North America | | |
        1. 4.4.1.1 US | | |
        2. 4.4.1.2 Canada | |
      2. 4.4.2 Europe | | |
        1. 4.4.2.1 Germany | | |
        2. 4.4.2.2 UK | | |
        3. 4.4.2.3 France | | |
        4. 4.4.2.4 Russia | | |
        5. 4.4.2.5 Italy | | |
        6. 4.4.2.6 Spain | | |
        7. 4.4.2.7 Rest of Europe | |
      3. 4.4.3 APAC | | |
        1. 4.4.3.1 China | | |
        2. 4.4.3.2 India | | |
        3. 4.4.3.3 Japan | | |
        4. 4.4.3.4 South Korea | | |
        5. 4.4.3.5 Malaysia | | |
        6. 4.4.3.6 Thailand | | |
        7. 4.4.3.7 Indonesia | | |
        8. 4.4.3.8 Rest of APAC | |
      4. 4.4.4 South America | | |
        1. 4.4.4.1 Brazil | | |
        2. 4.4.4.2 Mexico | | |
        3. 4.4.4.3 Argentina | | |
        4. 4.4.4.4 Rest of South America | |
      5. 4.4.5 MEA | | |
        1. 4.4.5.1 GCC Countries | | |
        2. 4.4.5.2 South Africa | | |
        3. 4.4.5.3 Rest of MEA 5
  5. SECTION V: COMPETITIVE ANALYSIS |
    1. 5.1 Competitive Landscape | |
      1. 5.1.1 Overview | |
      2. 5.1.2 Competitive Analysis | |
      3. 5.1.3 Market share Analysis | |
      4. 5.1.4 Major Growth Strategy in the Healthcare | |
      5. 5.1.5 Competitive Benchmarking | |
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare | |
      7. 5.1.7 Key developments and growth strategies | | |
        1. 5.1.7.1 New Product Launch/Service Deployment | | |
        2. 5.1.7.2 Merger & Acquisitions | | |
        3. 5.1.7.3 Joint Ventures | |
      8. 5.1.8 Major Players Financial Matrix | | |
        1. 5.1.8.1 Sales and Operating Income | | |
        2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
    2. 5.2 Company Profiles | |
      1. 5.2.1 Alltech (US) | | |
        1. 5.2.1.1 Financial Overview | | |
        2. 5.2.1.2 Products Offered | | |
        3. 5.2.1.3 Key Developments | | |
        4. 5.2.1.4 SWOT Analysis | | |
        5. 5.2.1.5 Key Strategies | |
      2. 5.2.2 Lesaffre (FR) | | |
        1. 5.2.2.1 Financial Overview | | |
        2. 5.2.2.2 Products Offered | | |
        3. 5.2.2.3 Key Developments | | |
        4. 5.2.2.4 SWOT Analysis | | |
        5. 5.2.2.5 Key Strategies | |
      3. 5.2.3 BASF (DE) | | |
        1. 5.2.3.1 Financial Overview | | |
        2. 5.2.3.2 Products Offered | | |
        3. 5.2.3.3 Key Developments | | |
        4. 5.2.3.4 SWOT Analysis | | |
        5. 5.2.3.5 Key Strategies | |
      4. 5.2.4 Nutreco (NL) | | |
        1. 5.2.4.1 Financial Overview | | |
        2. 5.2.4.2 Products Offered | | |
        3. 5.2.4.3 Key Developments | | |
        4. 5.2.4.4 SWOT Analysis | | |
        5. 5.2.4.5 Key Strategies | |
      5. 5.2.5 Angel Yeast (CN) | | |
        1. 5.2.5.1 Financial Overview | | |
        2. 5.2.5.2 Products Offered | | |
        3. 5.2.5.3 Key Developments | | |
        4. 5.2.5.4 SWOT Analysis | | |
        5. 5.2.5.5 Key Strategies | |
      6. 5.2.6 Yeast and Co (US) | | |
        1. 5.2.6.1 Financial Overview | | |
        2. 5.2.6.2 Products Offered | | |
        3. 5.2.6.3 Key Developments | | |
        4. 5.2.6.4 SWOT Analysis | | |
        5. 5.2.6.5 Key Strategies | |
      7. 5.2.7 Kerry Group (IE) | | |
        1. 5.2.7.1 Financial Overview | | |
        2. 5.2.7.2 Products Offered | | |
        3. 5.2.7.3 Key Developments | | |
        4. 5.2.7.4 SWOT Analysis | | |
        5. 5.2.7.5 Key Strategies | |
      8. 5.2.8 ABF Ingredients (GB) | | |
        1. 5.2.8.1 Financial Overview | | |
        2. 5.2.8.2 Products Offered | | |
        3. 5.2.8.3 Key Developments | | |
        4. 5.2.8.4 SWOT Analysis | | |
        5. 5.2.8.5 Key Strategies | |
      9. 5.2.9 Dsm Nutritional Products (CH) | | |
        1. 5.2.9.1 Financial Overview | | |
        2. 5.2.9.2 Products Offered | | |
        3. 5.2.9.3 Key Developments | | |
        4. 5.2.9.4 SWOT Analysis | | |
        5. 5.2.9.5 Key Strategies |
    3. 5.3 Appendix | |
      1. 5.3.1 References | |
      2. 5.3.2 Related Reports 6 LIST OF FIGURES |
    4. 6.1 MARKET SYNOPSIS |
    5. 6.2 NORTH AMERICA MARKET ANALYSIS |
    6. 6.3 US MARKET ANALYSIS BY TYPE |
    7. 6.4 US MARKET ANALYSIS BY FORM |
    8. 6.5 US MARKET ANALYSIS BY LIVESTOCK |
    9. 6.6 CANADA MARKET ANALYSIS BY TYPE |
    10. 6.7 CANADA MARKET ANALYSIS BY FORM |
    11. 6.8 CANADA MARKET ANALYSIS BY LIVESTOCK |
    12. 6.9 EUROPE MARKET ANALYSIS |
    13. 6.10 GERMANY MARKET ANALYSIS BY TYPE |
    14. 6.11 GERMANY MARKET ANALYSIS BY FORM |
    15. 6.12 GERMANY MARKET ANALYSIS BY LIVESTOCK |
    16. 6.13 UK MARKET ANALYSIS BY TYPE |
    17. 6.14 UK MARKET ANALYSIS BY FORM |
    18. 6.15 UK MARKET ANALYSIS BY LIVESTOCK |
    19. 6.16 FRANCE MARKET ANALYSIS BY TYPE |
    20. 6.17 FRANCE MARKET ANALYSIS BY FORM |
    21. 6.18 FRANCE MARKET ANALYSIS BY LIVESTOCK |
    22. 6.19 RUSSIA MARKET ANALYSIS BY TYPE |
    23. 6.20 RUSSIA MARKET ANALYSIS BY FORM |
    24. 6.21 RUSSIA MARKET ANALYSIS BY LIVESTOCK |
    25. 6.22 ITALY MARKET ANALYSIS BY TYPE |
    26. 6.23 ITALY MARKET ANALYSIS BY FORM |
    27. 6.24 ITALY MARKET ANALYSIS BY LIVESTOCK |
    28. 6.25 SPAIN MARKET ANALYSIS BY TYPE |
    29. 6.26 SPAIN MARKET ANALYSIS BY FORM |
    30. 6.27 SPAIN MARKET ANALYSIS BY LIVESTOCK |
    31. 6.28 REST OF EUROPE MARKET ANALYSIS BY TYPE |
    32. 6.29 REST OF EUROPE MARKET ANALYSIS BY FORM |
    33. 6.30 REST OF EUROPE MARKET ANALYSIS BY LIVESTOCK |
    34. 6.31 APAC MARKET ANALYSIS |
    35. 6.32 CHINA MARKET ANALYSIS BY TYPE |
    36. 6.33 CHINA MARKET ANALYSIS BY FORM |
    37. 6.34 CHINA MARKET ANALYSIS BY LIVESTOCK |
    38. 6.35 INDIA MARKET ANALYSIS BY TYPE |
    39. 6.36 INDIA MARKET ANALYSIS BY FORM |
    40. 6.37 INDIA MARKET ANALYSIS BY LIVESTOCK |
    41. 6.38 JAPAN MARKET ANALYSIS BY TYPE |
    42. 6.39 JAPAN MARKET ANALYSIS BY FORM |
    43. 6.40 JAPAN MARKET ANALYSIS BY LIVESTOCK |
    44. 6.41 SOUTH KOREA MARKET ANALYSIS BY TYPE |
    45. 6.42 SOUTH KOREA MARKET ANALYSIS BY FORM |
    46. 6.43 SOUTH KOREA MARKET ANALYSIS BY LIVESTOCK |
    47. 6.44 MALAYSIA MARKET ANALYSIS BY TYPE |
    48. 6.45 MALAYSIA MARKET ANALYSIS BY FORM |
    49. 6.46 MALAYSIA MARKET ANALYSIS BY LIVESTOCK |
    50. 6.47 THAILAND MARKET ANALYSIS BY TYPE |
    51. 6.48 THAILAND MARKET ANALYSIS BY FORM |
    52. 6.49 THAILAND MARKET ANALYSIS BY LIVESTOCK |
    53. 6.50 INDONESIA MARKET ANALYSIS BY TYPE |
    54. 6.51 INDONESIA MARKET ANALYSIS BY FORM |
    55. 6.52 INDONESIA MARKET ANALYSIS BY LIVESTOCK |
    56. 6.53 REST OF APAC MARKET ANALYSIS BY TYPE |
    57. 6.54 REST OF APAC MARKET ANALYSIS BY FORM |
    58. 6.55 REST OF APAC MARKET ANALYSIS BY LIVESTOCK |
    59. 6.56 SOUTH AMERICA MARKET ANALYSIS |
    60. 6.57 BRAZIL MARKET ANALYSIS BY TYPE |
    61. 6.58 BRAZIL MARKET ANALYSIS BY FORM |
    62. 6.59 BRAZIL MARKET ANALYSIS BY LIVESTOCK |
    63. 6.60 MEXICO MARKET ANALYSIS BY TYPE |
    64. 6.61 MEXICO MARKET ANALYSIS BY FORM |
    65. 6.62 MEXICO MARKET ANALYSIS BY LIVESTOCK |
    66. 6.63 ARGENTINA MARKET ANALYSIS BY TYPE |
    67. 6.64 ARGENTINA MARKET ANALYSIS BY FORM |
    68. 6.65 ARGENTINA MARKET ANALYSIS BY LIVESTOCK |
    69. 6.66 REST OF SOUTH AMERICA MARKET ANALYSIS BY TYPE |
    70. 6.67 REST OF SOUTH AMERICA MARKET ANALYSIS BY FORM |
    71. 6.68 REST OF SOUTH AMERICA MARKET ANALYSIS BY LIVESTOCK |
    72. 6.69 MEA MARKET ANALYSIS |
    73. 6.70 GCC COUNTRIES MARKET ANALYSIS BY TYPE |
    74. 6.71 GCC COUNTRIES MARKET ANALYSIS BY FORM |
    75. 6.72 GCC COUNTRIES MARKET ANALYSIS BY LIVESTOCK |
    76. 6.73 SOUTH AFRICA MARKET ANALYSIS BY TYPE |
    77. 6.74 SOUTH AFRICA MARKET ANALYSIS BY FORM |
    78. 6.75 SOUTH AFRICA MARKET ANALYSIS BY LIVESTOCK |
    79. 6.76 REST OF MEA MARKET ANALYSIS BY TYPE |
    80. 6.77 REST OF MEA MARKET ANALYSIS BY FORM |
    81. 6.78 REST OF MEA MARKET ANALYSIS BY LIVESTOCK |
    82. 6.79 KEY BUYING CRITERIA OF HEALTHCARE |
    83. 6.80 RESEARCH PROCESS OF MRFR |
    84. 6.81 DRO ANALYSIS OF HEALTHCARE |
    85. 6.82 DRIVERS IMPACT ANALYSIS: HEALTHCARE |
    86. 6.83 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE |
    87. 6.84 SUPPLY / VALUE CHAIN: HEALTHCARE |
    88. 6.85 HEALTHCARE, BY TYPE, 2024 (% SHARE) |
    89. 6.86 HEALTHCARE, BY TYPE, 2024 TO 2035 (USD Billion) |
    90. 6.87 HEALTHCARE, BY FORM, 2024 (% SHARE) |
    91. 6.88 HEALTHCARE, BY FORM, 2024 TO 2035 (USD Billion) |
    92. 6.89 HEALTHCARE, BY LIVESTOCK, 2024 (% SHARE) |
    93. 6.90 HEALTHCARE, BY LIVESTOCK, 2024 TO 2035 (USD Billion) |
    94. 6.91 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
    95. 7.1 LIST OF ASSUMPTIONS | |
      1. 7.1.1 |
    96. 7.2 North America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.2.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.2.2 BY FORM, 2025-2035 (USD Billion) | |
      3. 7.2.3 BY LIVESTOCK, 2025-2035 (USD Billion) |
    97. 7.3 US MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.3.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.3.2 BY FORM, 2025-2035 (USD Billion) | |
      3. 7.3.3 BY LIVESTOCK, 2025-2035 (USD Billion) |
    98. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.4.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.4.2 BY FORM, 2025-2035 (USD Billion) | |
      3. 7.4.3 BY LIVESTOCK, 2025-2035 (USD Billion) |
    99. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.5.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.5.2 BY FORM, 2025-2035 (USD Billion) | |
      3. 7.5.3 BY LIVESTOCK, 2025-2035 (USD Billion) |
    100. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.6.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.6.2 BY FORM, 2025-2035 (USD Billion) | |
      3. 7.6.3 BY LIVESTOCK, 2025-2035 (USD Billion) |
    101. 7.7 UK MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.7.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.7.2 BY FORM, 2025-2035 (USD Billion) | |
      3. 7.7.3 BY LIVESTOCK, 2025-2035 (USD Billion) |
    102. 7.8 France MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.8.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.8.2 BY FORM, 2025-2035 (USD Billion) | |
      3. 7.8.3 BY LIVESTOCK, 2025-2035 (USD Billion) |
    103. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.9.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.9.2 BY FORM, 2025-2035 (USD Billion) | |
      3. 7.9.3 BY LIVESTOCK, 2025-2035 (USD Billion) |
    104. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.10.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.10.2 BY FORM, 2025-2035 (USD Billion) | |
      3. 7.10.3 BY LIVESTOCK, 2025-2035 (USD Billion) |
    105. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.11.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.11.2 BY FORM, 2025-2035 (USD Billion) | |
      3. 7.11.3 BY LIVESTOCK, 2025-2035 (USD Billion) |
    106. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.12.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.12.2 BY FORM, 2025-2035 (USD Billion) | |
      3. 7.12.3 BY LIVESTOCK, 2025-2035 (USD Billion) |
    107. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.13.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.13.2 BY FORM, 2025-2035 (USD Billion) | |
      3. 7.13.3 BY LIVESTOCK, 2025-2035 (USD Billion) |
    108. 7.14 China MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.14.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.14.2 BY FORM, 2025-2035 (USD Billion) | |
      3. 7.14.3 BY LIVESTOCK, 2025-2035 (USD Billion) |
    109. 7.15 India MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.15.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.15.2 BY FORM, 2025-2035 (USD Billion) | |
      3. 7.15.3 BY LIVESTOCK, 2025-2035 (USD Billion) |
    110. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.16.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.16.2 BY FORM, 2025-2035 (USD Billion) | |
      3. 7.16.3 BY LIVESTOCK, 2025-2035 (USD Billion) |
    111. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.17.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.17.2 BY FORM, 2025-2035 (USD Billion) | |
      3. 7.17.3 BY LIVESTOCK, 2025-2035 (USD Billion) |
    112. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.18.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.18.2 BY FORM, 2025-2035 (USD Billion) | |
      3. 7.18.3 BY LIVESTOCK, 2025-2035 (USD Billion) |
    113. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.19.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.19.2 BY FORM, 2025-2035 (USD Billion) | |
      3. 7.19.3 BY LIVESTOCK, 2025-2035 (USD Billion) |
    114. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.20.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.20.2 BY FORM, 2025-2035 (USD Billion) | |
      3. 7.20.3 BY LIVESTOCK, 2025-2035 (USD Billion) |
    115. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.21.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.21.2 BY FORM, 2025-2035 (USD Billion) | |
      3. 7.21.3 BY LIVESTOCK, 2025-2035 (USD Billion) |
    116. 7.22 South America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.22.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.22.2 BY FORM, 2025-2035 (USD Billion) | |
      3. 7.22.3 BY LIVESTOCK, 2025-2035 (USD Billion) |
    117. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.23.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.23.2 BY FORM, 2025-2035 (USD Billion) | |
      3. 7.23.3 BY LIVESTOCK, 2025-2035 (USD Billion) |
    118. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.24.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.24.2 BY FORM, 2025-2035 (USD Billion) | |
      3. 7.24.3 BY LIVESTOCK, 2025-2035 (USD Billion) |
    119. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.25.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.25.2 BY FORM, 2025-2035 (USD Billion) | |
      3. 7.25.3 BY LIVESTOCK, 2025-2035 (USD Billion) |
    120. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.26.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.26.2 BY FORM, 2025-2035 (USD Billion) | |
      3. 7.26.3 BY LIVESTOCK, 2025-2035 (USD Billion) |
    121. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.27.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.27.2 BY FORM, 2025-2035 (USD Billion) | |
      3. 7.27.3 BY LIVESTOCK, 2025-2035 (USD Billion) |
    122. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.28.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.28.2 BY FORM, 2025-2035 (USD Billion) | |
      3. 7.28.3 BY LIVESTOCK, 2025-2035 (USD Billion) |
    123. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.29.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.29.2 BY FORM, 2025-2035 (USD Billion) | |
      3. 7.29.3 BY LIVESTOCK, 2025-2035 (USD Billion) |
    124. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.30.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.30.2 BY FORM, 2025-2035 (USD Billion) | |
      3. 7.30.3 BY LIVESTOCK, 2025-2035 (USD Billion) |
    125. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
      1. 7.31.1 |
    126. 7.32 ACQUISITION/PARTNERSHIP | |

Healthcare Market Segmentation

Healthcare By Type (USD Billion, 2025-2035)

  • Live Yeast
  • Spent Yeast
  • Yeast Derivatives
  • Others

Healthcare By Form (USD Billion, 2025-2035)

  • Powder
  • Liquid
  • Others

Healthcare By Livestock (USD Billion, 2025-2035)

  • Ruminants
  • Poultry
  • Swine
  • Others

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions